Targeting the Epigenetic Regulator CBX5 Promotes Fibroblast Metabolic Reprogramming and Inhibits Lung Fibrosis
American Journal of Respiratory Cell and Molecular Biology · 01.06.2025 · 72 (6) · 627-642
DOI: 10.1165/rcmb.2024-0255oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, online erschienen am 01.06.2025. Verfasst von Jeongmin Hong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine. Hauptthemen laut MEDLINE: Fibroblasts, Epigenesis, Genetic, Idiopathic Pulmonary Fibrosis, Cellular Reprogramming. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH/NHLBI, NCI NIH HHS.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is characterized by the sustained activation of interstitial fibroblasts leading to excessive collagen deposition and progressive organ failure. Epigenetic and metabolic abnormalities have been shown to contribute to the persistent activated state of scar-forming fibroblasts. However, how epigenetic changes regulate fibroblast metabolic responses to promote fibroblast activation and progressive fibrosis remains largely unknown. Here, we show that the epigenetic regulator CBX5 (chromobox protein homolog 5) is critical to the transition of quiescent fibroblasts to activated collagen-producing fibroblasts in response to bleomycin-induced lung injury. Loss of mesenchymal CBX5 attenuated fibrosis development, and this effect was accompanied by the downregulation of pathogenic fibroblast genes, including Cthrc1, Col1a1, and Spp1, and by the upregulation of metabolic genes with antifibrotic activity such as Ppara and Pparg. Single-cell RNA sequencing and immunohistochemistry analyses revealed that CBX5 expression was enriched in pathogenic fibroblasts and fibroblastic foci of IPF lungs. Bulk RNA-sequencing analysis combined with metabolic assessments demonstrated that CBX5 silencing in IPF fibroblasts potently inhibited transforming growth factor–stimulated glycolysis while enhancing AMPK signaling and mitochondrial metabolism. Finally, interruption of the CBX5 pathway in IPF fibroblasts in vitro and in IPF lung explants ex vivo synergistically potentiated the activation of metformin-induced AMP-activated protein kinase activation and inhibited collagen secretion. Collectively, our findings identify CBX5 as an epigenetic regulator linking metabolic maladaptation to the persistent activated state of lung fibroblasts during IPF progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine.
- Pulmonary Center, and.
- Department of Zoology, Assiut University, Assiut, Egypt.
- Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts.
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
- Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin; and.
ORCID-Profile: Jeongmin Hong, Steven K Huang, Giovanni Ligresti
Förderung
- NHLBI NIH HHS
- NIH/NHLBI
- NCI NIH HHS
Zitieren
APA
Hong, J., Pham, T. X., Lee, J., Raslan, A. A., Nicolas, K., Sharov, A., Meridew, J. A., Urrutia, R. A., Lomberk, G., Huang, S. K., & Ligresti, G. (2025). Targeting the Epigenetic Regulator CBX5 Promotes Fibroblast Metabolic Reprogramming and Inhibits Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology, 72(6), 627-642. https://doi.org/10.1165/rcmb.2024-0255oc
Vancouver
Hong J, Pham TX, Lee J, Raslan AA, Nicolas K, Sharov A, et al. Targeting the Epigenetic Regulator CBX5 Promotes Fibroblast Metabolic Reprogramming and Inhibits Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 2025;72(6):627-642. doi:10.1165/rcmb.2024-0255oc
BibTeX
@article{Hong2025,
author = {Hong, Jeongmin and Pham, Tho X and Lee, Jisu and Raslan, Ahmed A and Nicolas, Kristina and Sharov, Andrei and Meridew, Jeffrey A and Urrutia, Raul A and Lomberk, Gwen and Huang, Steven K and Ligresti, Giovanni},
title = {Targeting the Epigenetic Regulator CBX5 Promotes Fibroblast Metabolic Reprogramming and Inhibits Lung Fibrosis},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2025},
volume = {72},
number = {6},
pages = {627--642},
doi = {10.1165/rcmb.2024-0255oc}
}
EUVIMED